Vaccine Argentine hemorrhagic fever
the candid #1 vaccine ahf created in 1985 argentine virologist dr. julio barrera oro. vaccine manufactured salk institute in united states, , became available in argentina in 1990.
candid #1 has been applied adult high-risk population , 95.5% effective. on 29 august 2006 maiztegui institute obtained certification production of vaccine in argentina. vaccination plan yet outlined, budget 2007 allows 390,000 doses, @ ar$8 each (about us$2.6 or €2 @ time). institute has capacity manufacture, in 1 year, 5 million doses required vaccinate entire population of endemic area.
between 1991 , 2005 more 240,000 people vaccinated, achieving great decrease in numbers of reported cases (94 suspect , 19 confirmed in 2005).
the junÃn vaccine has shown cross-reactivity machupo virus and, such, has been considered potential treatment bolivian hemorrhagic fever.
Comments
Post a Comment